Invivyd Inc

Insider trades show Invivyd execs buying while selling to cover taxes—less than 0.5% dilution—signaling confidence ahead of LIBERTY Phase 3 results.

Invivyd insiders’ synchronized stock‑option buys signal confidence; CFO’s 625k‑share grant and 2.8M options suggest the company may rebound to $3.07 after key COVID‑19 antibody milestones.